NBIX
$NBIX
Neurocrine Biosciences, Inc.
Neuroscience-focused biotech developing treatments for neurological and endocrine disorders.
Healthcare$159.00
+2.58 (+1.65%)
Day Range$155.66 - $160.02
Prev Close$156.42
Analyst Rating
Strong Buy
31 Buy / 5 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
NBIX: Soleno Buyout Boosts Growth Outlook
Neurocrine Biosciences ($NBIX) is trading at $129.98 after announcing a $2.9B acquisition of Soleno Therapeutics that expands its obesity and rare-disease pipeline. Analysts remain constructive with a Strong Buy consensus and a mean price target around $178, implying roughly 37% upside.
Apr 6, 2026